Episode 83
BoC slashes rates as building permits plunge – AstraZeneca’s $820M bet and Starlight’s real estate takeover
Commercial Real Estate Insights Podcast
March 12, 20253m 34s
Audio is streamed directly from the publisher (media.podcastai.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Steven Hamoen begins with an introduction and provides economic updates relevant to the commercial real estate landscape. He discusses AstraZeneca's significant investment in Canada, analyzing its potential impact on the real estate sector, particularly in life sciences and associated industries. The conversation then shifts to Starlight Investments, highlighting its recent growth and strategic initiatives within the commercial real estate market. Steven concludes with closing remarks, encouraging listeners to consider these developments in their investment strategies.
(0:00) Introduction and Economic Updates
(1:47) AstraZeneca's investment in Canada and Starlight Investments' growth
(3:17) Closing remarks